May  Faraj, PhD

May Faraj, PhD

Universite de Montreal

Professor Faculty of Medicine - Department of Nutrition

Expertise: DiabetesDiabetesMetabolic DisordersMetabolic DisordersObesityObesity

Research units

Research expertise

  • Obesity, prediabetes and type 2 diabetes
  • Lipoprotein metabolism
  • Physiology of white adipose tissue
  • Nutritional interventions
  • Human studies

Our clinical and fundamental research studies novel mechanisms that may lead to the development of cardiometabolic diseases in humans, such as type 2 diabetes and atherosclerosis. More particularly, we study the role of atherogenic lipoproteins and dysfunctional adipose tissue in this process. Furthermore, we examine the effect of various nutritional interventions as therapeutic tools that could reverse early cardiometabolic abnormalities. These projects will contribute to the prevention of type 2 diabetes in humans, particularly in subjects with obesity.

 Member

 

  • Adjunct professor, Division of Experimental Medicine, Faculty of Medicine, McGill University
  • Researcher, Montreal Diabetes Research Center (CRDM)

Professional titles and affiliations

Titles: corporations and professional organizations

  • Member, Order of Dietitians-Nutritionists of Quebec (ODNQ)

Disciplines

  • Clinical Sciences
  • Endocrinology and Metabolism
  • Nutrition
  • Biochemistry
  • Medical Biochemistry
  • Physiology

Areas of expertise

  • Obesity
  • Diabetes
  • Metabolism
  • Metabolic Disorders
  • Metabolic Diseases
  • Physiology
  • Nutritional Disorders
  • Nutrition
  • Atherosclerosis
  • Tassels and Fabrics
  • Lipid Disorders
  • Menopause
  • Age and Risk Factors
  • Cardiovascular Diseases
  • Health Prevention
  • Health Promotion
  • Americas
  • Canada (Quebec)
  • 2000 AD - Present

No Research/Citations

Type 2 diabetes: a new disease mechanism uncovered

Published just before World Diabetes Day, work by Dr. May Faraj, director of the Research Unit on Nutrition, Lipoproteins and Cardiometabolic Diseases at the Montreal Clinical Research Institute (IRCM) and full professor at the Department of Nutrition at the University of Montreal, highlight a new mechanism and a new role for LDL – commonly called bad cholesterol – in the development of type 2 diabetes, LDL already being involved in cardiovascular diseases in the human.
21-Nov-2023 08:05:02 AM EST

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video

close
0.08264